Matthew McAviney, M.D.
Matt is a Principal at F-Prime Capital and focuses primarily on the biopharmaceutical and medical technology sectors. Prior to joining F-Prime in 2013, Matt was a healthcare consultant at Oliver Wyman, a biotech equity analyst at Robert W. Baird, and a healthcare investment banker at J.P. Morgan. He began his career researching lipid metabolism at the NIH.
Matt holds a M.D. from the University of Illinois and a M.B.A. from the University of Chicago. He received his B.A. in biology with honors from the University of Chicago.